Kaiser Permanente workers strike for second day after negotiations fail to reach labor contract

Kaiser Permanente workers strike for second day after negotiations fail to reach labor contract


Kaiser Permanente employees, joined by Union members representing the workers, walk the picket line in Los Angeles, California on October 4, 2023. 

Frederic J. Brown | AFP | Getty Images

Tens of thousands of Kaiser Permanente workers remained on strike for a second day after negotiators failed to reach an agreement to end a dispute over a short-staffing crisis at health facilities.

A spokesperson for the Coalition of Kaiser Permanente Unions, said that the strike — said to be the largest health-care worker walkout in U.S. history — will continue until Saturday morning at the latest as the group waits for “a meaningful response from Kaiser executives” to its demands.

There are currently no bargaining sessions scheduled with Kaiser, said the spokesperson, Caroline Lucas.

More than 75,000 workers went on strike Wednesday at hundreds of Kaiser Permanente health facilities in California, Colorado, the District of Columbia, Oregon, Virginia and Washington state.

Nearly 60,000 of those workers are in California.

Kaiser Permanente workers in D.C. and Virginia struck for one day and returned to work Thursday, but will continue in the other four states through Saturday morning “barring any dramatic action from Kaiser executives to address the short staffing crisis,” Lucas said.

CNBC Health & Science

Read CNBC’s latest health coverage:

Operations, chemotherapy treatments and other “non-urgent” procedures were postponed Wednesday due to the strike, NBC News reported.

Kaiser Permanente has said all hospitals and emergency departments will remain open during the work stoppage, but elective procedures may have to be postponed.

Kaiser Permanente is the largest private, nonprofit health-care organization in the U.S.

It serves nearly 13 million patients and operates 39 hospitals and more than 600 medical offices across eight states and D.C.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More